Ali Ozler1, Naci Kemal Kuşçu2, Peyker Temiz3, Ali Rıza Kandiloğlu3, Faik Mümtaz Koyuncu2. 1. Department of Obstetrics and Gynecology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey. 2. Department of Obstetrics and Gynecology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey. 3. Department of Pathology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.
Abstract
OBJECTIVE: The goal of this study was to detect endometrial leptin expression in proliferative and secretory phases and then to compare the results with that of hyperplastic endometrium. MATERIAL AND METHODS: Seventeen proliferative, 23 secretory phase and 18 hyperplastic endometrial tissues diagnosed in our hospital between 2002 and 2007 were included in the study. These samples were stained with leptin antibody using an immunohistochemical method. Endometrial glandular and surface epithelium and stroma were evaluated for staining distribution and intensity. CONCLUSION: Staining intensity seen in early proliferative phase samples (2.33±0.51) increased significantly throughout the middle (2.40±0.54) and late phases (2.83±0.40) (p<0.05). Early secretory phase samples had the least staining intensity (1.42±0.53), while it increased significantly in later periods (2.38±0.51) (p<0.05). There was no difference in staining intensity among proliferative, secretory and hyperplastic tissues (p>0.05). CONCLUSION: Although endometrial leptin expression was observed in a differential manner throughout the whole menstrual period, no difference was seen in endometrial hyperplasia. We consider that leptin does not play a role in hyperplastic transformation of the endometrium.
OBJECTIVE: The goal of this study was to detect endometrial leptin expression in proliferative and secretory phases and then to compare the results with that of hyperplastic endometrium. MATERIAL AND METHODS: Seventeen proliferative, 23 secretory phase and 18 hyperplastic endometrial tissues diagnosed in our hospital between 2002 and 2007 were included in the study. These samples were stained with leptin antibody using an immunohistochemical method. Endometrial glandular and surface epithelium and stroma were evaluated for staining distribution and intensity. CONCLUSION: Staining intensity seen in early proliferative phase samples (2.33±0.51) increased significantly throughout the middle (2.40±0.54) and late phases (2.83±0.40) (p<0.05). Early secretory phase samples had the least staining intensity (1.42±0.53), while it increased significantly in later periods (2.38±0.51) (p<0.05). There was no difference in staining intensity among proliferative, secretory and hyperplastic tissues (p>0.05). CONCLUSION: Although endometrial leptin expression was observed in a differential manner throughout the whole menstrual period, no difference was seen in endometrial hyperplasia. We consider that leptin does not play a role in hyperplastic transformation of the endometrium.
Authors: Anne Lautenbach; Anne Budde; Christiane D Wrann; Birgit Teichmann; Gertrud Vieten; Tim Karl; Heike Nave Journal: Nutr Cancer Date: 2009 Impact factor: 2.900
Authors: J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman Journal: Science Date: 1995-07-28 Impact factor: 47.728
Authors: R R González; P Caballero-Campo; M Jasper; A Mercader; L Devoto; A Pellicer; C Simon Journal: J Clin Endocrinol Metab Date: 2000-12 Impact factor: 5.958